Dr. Aaron Schimmer appointed new Research Director of Princess Margaret Cancer Centre

Dr. Aaron Schimmer has been appointed the new Research Director of Princess Margaret Cancer Centre, effective February 15.

Since 2003, Dr. Schimmer has been an active clinician and researcher at The Princess Margaret. He has established a vibrant and highly collaborative translational research program focused on developing innovative therapeutic strategies to target leukemia and leukemia stem cells that has advanced three compounds directly from his lab into Phase I clinical trials.

Dr. Schimmer is also a recognized authority in the cancer research field, publishing more than 217 peer-reviewed papers over the course of his career, with many in high impact journals.  His work in novel therapeutics has resulted in over 15 patents and patent applications. Dr. Schimmer is also the recipient of numerous prestigious research awards, including the Till and McCulloch Award and the Bernard and Francine Dorval Prize. He is a Professor in the University of Toronto's Department of Medicine, the Institute of Medical Science and the Department of Medical Biophysics.

In addition to advancing his own research program, Dr. Schimmer has continuously made significant contributions to clinical practice, research and education. He has served on many international organizations, grant review panels, including the CIHR, NIH and NCI, and has participated on numerous committees at The Princess Margaret and University of Toronto. Dr. Schimmer has also served as the Interim Associate Director of Research at The Princess Margaret since January 2018.